Improving the use of technology in clinical trials is now a prime opportunity for the life sciences industry. With the right tools, sponsors can enhance the efficiency of trial execution, provide patients with new ways to participate in studies, and simplify collaboration with clinical sites....
We need to widen the data net and do a better job of analyzing those data to identify clinical trials participants from previously ignored patient populations....
Obstacles exist, but the clinical trials sector can make small changes to make transgender, nonbinary individuals feel safe to join studies....
Researchers estimate that COVID-19 vaccine shots prevented 1.9 million deaths in the United States during the first year they became available....
It’s probably time to remove the cookie-cutter mentality from your clinical trials operational tool kit....
The challenges of the pandemic may have given the clinical research profession the gift of perspective that will positively affect the outlook on our industry’s collective future....
The Centers for Disease Control and Prevention authorized the COVID-19 vaccine for kids under five and UW Health experts say they’re ready to start rolling out vaccinations in Wisconsin....
The University of Wisconsin System Board of Regents last week approved revisions to contract approval policies that will provide greater flexibility for UW–Madison related to approval of research and clinical trials and athletic employment contracts....
Although many clinical trial sponsors are broadly aware of the need for more diverse participation, most still struggle to implement specific, structural changes that will help trials better represent the wider population....
Clinical trials largely fail to enroll diverse patient populations — and in the last couple of years, patient advocates, the FDA and even a slate of pharma companies have taken steps to change that....
